University of Wisconsin–Madison

David P Foley, MD

Associate Professor

  • Section of Liver and Kidney Surgery
  • Division of Transplantation
  • Program Director, Abdominal Transplant Surgery Fellowship

foley@surgery.wisc.edu
(608) 263-2527

600 HIGHLAND AVE
MC 7375
MADISON, WI 53792-3284

Education

  • MD, Boston University, 1994
  • General Surgery Residency, University of Massachusetts Medical School, 1994-2001
  • Surgical Research Fellowship, University of Massachusetts Department of Surgery, 1996-1998
  • Transplant Surgical Fellow, University of Wisconsin Hospital and Clinics, Madison, WI, 2001-2003

Honors

Castle Connolly America’s Top Doctors Surgery

Madison Magazine Top Docs 2016 Award Surgery, Transplantation

Dr. Foley is involved with the following professional societies:

  • American Society of Transplant Surgeons
  • American Society of Transplantation
  • American Association for the Study of Liver Diseases
  • Association for Academic Surgery
  • Surgical Biology Club II
  • Society of University Surgeons
  • Central Surgical Association
  • Transplantation Society
  • Americas Hepato-Pancreato-Biliary Association
  • International Liver Transplant Society

Dr. Foley has been very active in leadership positions in national surgical and transplant societies. He has served as Co-Chair for the Grants Review Committee for the American Society of Transplant Surgeons. He served on the Executive Committee for the Association for Academic Surgery and Co-Chair of the Education Committee. He has been the Co-Chair and Chair of the Executive Committee for the Liver and Intestine Community of Practice for the American Society of Transplantation.

Clinical Specialties

Dr. Foley is certified by the American Board of Surgery in General Surgery. Dr. Foley’s clinical focus is in liver and kidney transplantation. Dr. Foley provides a wide range of services including kidney transplant, laparoscopic donor nephrectomy, liver resection, and liver transplant.

Research Interests

Dr. Foley’s clinical research interests include studying protective strategies to decrease organ damage and enhance organ function after kidney and liver transplantation. Dr. Foley focuses on identifying and modifying clinical risk factors that lead to poor liver function after liver transplantation. These include studying the use of older donor livers, livers recovered from donation after circulatory determination of death donors, and livers with steatosis. In addition, Dr. Foley leads clinical studies aimed at decreasing delayed kidney function after kidney transplantation.

Dr. Foley’s basic research efforts are focused on identifying novel protective strategies to minimize ischemia-reperfusion injury (IRI) in liver and kidney transplantation. More specifically, his laboratory investigates the cell-specific effects of augmenting endogenous antioxidant pathways in the setting of hepatic and renal IRI. Activation of these pathways in a cell-specific manner can decrease oxidative stress and may promote cellular recovery from these deleterious processes. The ultimate goal is to discover new pharmacologic therapies that can decrease IRI and improve organ function after kidney and liver transplantation.

Recent Publications:

    • An Evaluation of the Safety and Efficacy of Simultaneous Bilateral Nephrectomy and Renal Transplantation for Polycystic Kidney Disease: A 20-Year Experience.
    • Grodstein EI, Baggett N, Wayne S, Leverson G, D'Alessandro AM, Fernandez LA, Foley DP, Mezrich JD, Odorico JS, Redfield RR, Sollinger HW, Kaufman DB
    • Transplantation 2017 Nov; 101(11): 2774-2779
    • [PubMed ID: 29064957]
    • Interpreting Outcomes in DCDD Liver Transplantation: First Report of the Multicenter IDOL Consortium.
    • Goldberg DS, Karp SJ, McCauley ME, Markmann JF, Croome KP, Taner CB, Heimbach JK, Leise MD, Fryer JP, Bohorquez HE, Cohen AJ, Gilroy RK, Kumer SC, Foley DP, Karim AS, Hernandez-Alejandro R, Levstik MA, Abt PL
    • Transplantation 2017 May; 101(5): 1067-1073
    • [PubMed ID: 28114173]
    • Liver transplant outcomes using ideal donation after circulatory death livers are superior to using older donation after brain death donor livers.
    • Scalea JR, Redfield RR, Foley DP
    • Liver Transpl. 2016 09; 22(9): 1197-204
    • [PubMed ID: 27314220]
    • Cell-specific overactivation of nuclear erythroid 2 p45-related factor 2-mediated gene expression in myeloid cells decreases hepatic ischemia/reperfusion injury.
    • Lee LY, Harberg C, Matkowskyj KA, Cook S, Roenneburg D, Werner S, Johnson DA, Johnson JA, Foley DP
    • Liver Transpl. 2016 08; 22(8): 1115-28
    • [PubMed ID: 27113842]
    • Does DCD Donor Time-to-Death Affect Recipient Outcomes? Implications of Time-to-Death at a High-Volume Center in the United States.
    • Scalea JR, Redfield RR, Arpali E, Leverson GE, Bennett RJ, Anderson ME, Kaufman DB, Fernandez LA, D'Alessandro AM, Foley DP, Mezrich JD
    • Am. J. Transplant. 2017 Jan; 17(1): 191-200
    • [PubMed ID: 27375072]

All Publications on PubMed